Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Oaxaca City
Clinical trial register · Mexico

Clinical Trials in Oaxaca City, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 591 Monterrey 374 Guadalajara 348 Chihuahua City 175 Mérida 133
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC33 Bristol-Myers Squibb12 Pfizer10 Hoffmann-La Roche8 Eli Lilly and Company6
Site location
Mexico City591 Monterrey374 Guadalajara348 Chihuahua City175 Mérida133
All 197 locations
Target enrolment
to

Trials with a site in Oaxaca City

123 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Aguascalientes, Chihuahua City, México, Metepec, Guadalajara, Morelia, Monterrey, Oaxaca City
2026-12-16
Recruiting
Takeda
Phase 3
324
Huixquilucan, Monterrey, Oaxaca City
2026-09-10
Not yet open
Carnot Laboratories
Phase 3
374
Mexico City, Pachuca, Guadalajara, Monterrey, Oaxaca City
2026-09
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Benito Juárez, Chihuahua City, Coyocan, León, Mérida, Monterrey, Oaxaca City, Pachuca
2026-06-11
Recruiting
Takeda
Phase 3
300
Morelia, Monterrey, Mexico City, Oaxaca City
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
630
Guadalajara, Col Roma Norte, Distrito Federal, San Nicolás de los Garza, Oaxaca City, Puebla City
2026-04-13
Recruiting
Hoffmann-La Roche
Phase 2
80
Distrito Federal, Oaxaca City, Guadalajara
2026-04-07
Recruiting
Bristol-Myers Squibb
Phase 1/2
474
Monterrey, Oaxaca City, Puebla City, Tlalpan
2026-03-26
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Mexico City, Oaxaca City
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Guadalajara, Zapopan, Mexico City, Monterrey, Oaxaca City, Puebla City, Querétaro
2026-03-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Guadalajara, Benito Juárez, Mexico City, Monterrey, Chihuahua City, Oaxaca City
2026-01-19
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Tijuana, Guadalajara, Zapopan, Mexico City, Monterrey, Oaxaca City, Chihuahua City, Puebla City
2026-01-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Guadalajara, Monterrey, Oaxaca City, Mexico City, Puebla City
2025-11-26
Recruiting
Summit Therapeutics
Phase 3
600
Aguas Calientes, Mexico City, Monterrey, Oaxaca City
2025-11-18
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Mexico City, Oaxaca City, Chihuahua City
2025-11-05
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Zapopan, Cuauhtémoc, Ciudad de México, Mexico City, Monterrey, Oaxaca City, Mérida, Puebla City, Querétaro
2025-10-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Guadalajara, Benito Juárez, Monterrey, Oaxaca City, Chihuahua City, Mexico City, Puebla City
2025-10-08
Recruiting
Pfizer
Phase 2/3
982
Guadalajara, Oaxaca City, San Luis Potosí City
2025-10-03
Recruiting
Pfizer
Phase 3
680
Guadalajara, Oaxaca City, Puebla City
2025-09-29
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Mexico City, Tijuana, Guadalajara, Monterrey, Oaxaca City, Mérida, Chihuahua City
2025-09-11
Recruiting
BeOne Medicines
Phase 3
500
México, Monterrey, Oaxaca City, Toluca
2025-09-04
Recruiting
BeOne Medicines
Phase 3
351
Mexico City, Mérida, Oaxaca City
2025-08-27
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
153
Monterrey, Oaxaca City, Huixquilucan
2025-08-21
Recruiting
Pfizer
Phase 3
400
Oaxaca City, Mexico City
2025-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Guadalajara, Monterrey, Querétaro City, Chihuahua City, Oaxaca City
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Guadalajara, Mexico City, Monterrey, San Pedro Garza García, Aguascalientes, Oaxaca City
2025-07-16
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Chihuahua City, León, Mexico City, Oaxaca City, Pachuca, Tlalnepantla, Veracruz de Ignacio de La Llave
2025-06-09
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Mexico City, Oaxaca City
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Guadalajara, Monterrey, Oaxaca City, Aguascalientes, Chihuahua City
2025-05-22
Recruiting
Novartis Pharmaceuticals
Phase 3
348
León, Oaxaca City, Querétaro
2025-05-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Pachuca, Guadalajara, Mexico City, Monterrey, Oaxaca City
2025-05-13
Recruiting
Hoffmann-La Roche
Phase 3
450
Distrito Federal, MexicoCiudad de México, Monterrey, Ciudad de Huajuapan de León, Oaxaca City, Chihuahua City, D.F., Guadalajara
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Guadalajara, Mexico City, Monterrey, Aguascalientes, Cuauhtémoc, Oaxaca City
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Guadalajara, Benito Juárez, Mexico City, Monterrey, San Pedro Garza García, Oaxaca City, Aguascalientes, Chihuahua City
2025-03-16
Recruiting
Summit Therapeutics
Phase 3
780
Aguascalientes, Guadalajara, Querétaro, Oaxaca City, Jalisco, Mexico City, Monterrey, Veracruz
2025-02-27
Active, closed
Zura Bio Inc
Phase 2
80
Chihuahua City, Guadalajara, Mérida, Miguel Hidalgo, Oaxaca City
2025-02-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Torreón, Pachuca, Mexico City, Morelia, Monterrey, Oaxaca City
2025-01-27
Active, closed
Vicore Pharma AB
Phase 2
378
Mexico City, Monterrey, San Nicolás de los Garza, Oaxaca City
2024-12-09
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Monterrey, San Nicolás de los Garza, San Juan del Río, Chihuahua City, Mexico City, Oaxaca City, Puebla City
2024-11-15
By invitation
Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico
NCT06683235DIABETES Mellitus Type 2 Not Well Controlled
Universidad Autónoma Benito Juárez de Oaxaca
Not applicable
160
Oaxaca City
2024-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
66
Mexico City, Oaxaca City
2024-10-14
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Mexico City, Guadalajara, Mérida, Oaxaca City
2024-09-17
Active, closed
GlaxoSmithKline
Phase 3
10,212
Chihuahua City, León, Mexico City, Mérida, Monterrey, Oaxaca City, Querétaro, RM Pharmamexico CITY
2024-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Mexico City, San Pedro Garza García, Oaxaca City, Aguascalientes, San Luis Potosí City
2024-07-24
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Durango, Irapuato, Jalisco, Mexico City, Distrito Federal, Mérida, Morelia, Oaxaca City, Querétaro
2024-07-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Chihuahua City, Mexico City, Oaxaca City
2024-07-16
Active, closed
Celgene
Phase 3
850
Mexico City, Morelia, Monterrey, Oaxaca City, Puebla City
2024-06-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Guadalajara, Mexico City, Monterrey, Oaxaca City
2024-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
León, Tlajomulco de Zúñiga, Mexico City, Cuernavaca, Monterrey, San Pedro Garza García, Oaxaca City, Mérida
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Mexico City, Monterrey, Oaxaca City
2024-05-24
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Chihuahua City, Coyoacán, León, Mexico City, Monterrey, Oaxaca City
2024-05-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Guadalajara, Mexico City, Monterrey, Oaxaca City, San Luis Potosí City
2024-05-03
Recruiting
Eli Lilly and Company
Phase 3
510
Aguascalientes, Chihuahua City, Guadalajara Jalsico, Nuevo León, Oaxaca City
2024-04-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Guadalajara, Monterrey, Oaxaca City, Chihuahua City
2024-04-03
Recruiting
GlaxoSmithKline
Phase 3
864
Guadajalara, Guadalajara, Mexico City, Monterrey, Oaxaca City
2024-03-21
Recruiting
Novartis Pharmaceuticals
Phase 2
108
Oaxaca City, Veracruz
2024-02-20
Active, closed
Pfizer
Phase 2
333
Mexico City, Monterrey, Oaxaca City, Veracruz
2024-01-09
Recruiting
Eli Lilly and Company
Phase 3
1,264
Guadalajara, Juriquilla, León, Mexico City, Monterrey, Oaxaca City, Puebla City, San Pedro Garza García
2023-12-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Oaxaca City, Puebla City
2023-12-15
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Guadalajara, Mexico City, Monterrey, Oaxaca City, Queréaro
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Coyoacán, Mexico City, San Pedro Garza García, Oaxaca City
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Pachuca, Guadalajara, Mexico City, Monterrey, Chihuahua City, Distrito Federal, Oaxaca City
2023-12-06
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Guadalajara, Mexico City, Puebla City, San Luis Potosí City, Monterrey, Oaxaca City, Sinaloa
2023-11-16
Recruiting
Amgen
Phase 3
750
Guadalajara, Mexico City, Monterrey, Oaxaca City
2023-11-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Guadalajara, Monterrey, Oaxaca City, Puebla City
2023-11-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
León, Guadalajara, Tlajumulco de Zuniga, Mexico City, Monterrey, Mérida, Chihuahua City, Oaxaca City
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Aguascalientes, México, Guadalajara, Morelia, Oaxaca City, Córdoba, Mérida, Chihuahua City
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Oaxaca City, Huixquilucan, Mexico City, Puebla City
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Metepec, Morelia, Oaxaca City
2023-09-14
Active, closed
Hoffmann-La Roche
Phase 3
687
Mexico City, Oaxaca City
2023-09-14
Active, closed
Boehringer Ingelheim
Phase 2
268
Chihuahua City, Monterrey, Monterrey, Nuevo León, Oaxaca City, Tlalnepantla
2023-09-08
Recruiting
Gilead Sciences
Phase 3
402
Cuernavaca, Irapuato, Mexico City, México, Oaxaca City, Veracruz
2023-09-07
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Chihuahua City, Guadalajara, Monterrey, Oaxaca City, Villahermosa
2023-08-30
Recruiting
GlaxoSmithKline
Phase 3
892
DF, Guadalajara, Mexico City, Oaxaca City, San Pedro Garza García, Tijuana
2023-08-01
Active, closed
Hoffmann-La Roche
Phase 2
83
Mexico City, Monterrey, Oaxaca City
2023-07-18
Active, closed
Alumis Inc
Phase 2
408
Naucalpan, Chihuahua City, Cuauhtémoc, Guadalajara, Madero, Mexico City, Mérida, Oaxaca City
2023-06-26
Active, closed
Viatris Innovation GmbH
Phase 3
451
Cuernavaca, Guadalajara, León, Mexico City, Mérida, Monterrey, Oaxaca City, Querétaro
2023-06-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Mexico City, Morelia, Oaxaca City
2023-03-16
Active, closed
Pfizer
Phase 3
624
Guadajalara, Cuauhtémoc, Oaxaca City
2023-03-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Tijuana, Monterrey, Mérida, Aguascalientes, Oaxaca City
2023-02-06
Active, closed
Daiichi Sankyo
Phase 3
1,170
Cuauhtémoc, Guadalajara, Mexico City, Oaxaca City
2023-01-11
Active, closed
Gilead Sciences
Phase 3
1,021
México, Mitras Centro, Oaxaca City, Orizaba Centro, Puebla City, Veracruz
2022-10-12
Active, closed
Eli Lilly and Company
Phase 3
8,000
Chihuahua City, Ciudad Madero, Guadalajara, León, Mexico City, Monterrey, Oaxaca City, Puebla City
2022-10-04
Active, closed
PureTech
Phase 2
240
Monterrey, San Nicolás de los Garza, Calpulalpan, Oaxaca City, San Pedro Garza García
2022-07-22
Active, closed
Novartis Pharmaceuticals
Phase 3
452
León, Monterrey, Oaxaca City, Querétaro
2022-07-14
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Aguascalientes, Monterrey, Oaxaca City
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
925
Guadalajara, Mexico City, Monterrey, Culiacán, Chihuahua City, Oaxaca City
2022-04-14
Active, closed
AstraZeneca
Phase 3
1,035
Aguascalientes, Culiacán, Guadalajara, Mexico City, México, Oaxaca City, Zapopan
2022-03-25
Recruiting
AbbVie
Phase 3
768
Guadalajara, Morelia, Oaxaca City
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Guadalajara, Mexico City, Monterrey, Oaxaca City
2022-03-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Guadalajara, Mexico City, Monterrey, Querétaro City, Culiacán, Oaxaca City, Puebla City
2022-03-15
Active, closed
Daiichi Sankyo
Phase 3
740
Cuauhtémoc, Guadalajara, Monterrey, Oaxaca City, San Luis Potosí City
2022-03-04
Active, closed
AstraZeneca
Phase 3
791
Chihuahua City, Guadalajara, Mexico City, Oaxaca City
2022-02-18
Active, closed
Sanofi
Phase 4
1,339
Guadalajara, Mexico City, Monterrey, San Juan del Río, Villahermosa, Chihuahua City, Durango, Oaxaca City
2021-12-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
La Paz, Mexico City, Monterrey, Oaxaca City
2021-12-13
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Mexico City, Monterrey, Oaxaca City
2021-12-02
Active, closed
AbbVie
Observational
873
Guadalajara, Mexico City, Monterrey, San Pedro Garza García, Oaxaca City, San Andrés Cholula, Toluca, Mérida
2021-11-17
Active, closed
Eli Lilly and Company
Phase 3
874
Torreón, Álvaro Obregón, Mexico City, Monterrey, San Pedro Garza García, Chihuahua City, Oaxaca City, Puebla City
2021-10-04
Recruiting
Pfizer
Phase 3
893
Colonia Valle de Las Palmas, Monterrey, Oaxaca City, Veracruz
2021-10-04
Active, closed
Pfizer
Phase 3
77
Monterrey, Oaxaca City
2021-09-29
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Mexicali, León, Guadalajara, Mexico City, Monterrey, Oaxaca City, Querétaro City, Culiacán
2021-08-27
Active, closed
Inventiva Pharma
Phase 3
1,000
Guadalajara, Cuauhtémoc, Mexico City, Cuernavaca, Monterrey, Mérida, Metepec, Oaxaca City
2021-08-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Guadalajara, Mexico City, Monterrey, Chihuahua City, Oaxaca City
2021-06-18
Active, closed
Pfizer
Phase 3
599
León, Monterrey, Oaxaca City, Naucalpan, Veracruz
2021-05-12
Active, closed
Hoffmann-La Roche
Phase 3
1,188
La Paz, Distrito Federal, Mexico City, Monterrey, Oaxaca City
2021-05-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Guadalajara, Mexico City, Monterrey, Querétaro City, Oaxaca City
2021-04-14
Active, closed
BioNTech SE
Phase 2/3
358
Tuxtla Gutiérrez, Chihuahua City, Guadalajara, Mexico City, Monterrey, Oaxaca City, Veracruz, Yucatán
2021-01-07
Active, closed
Pfizer
Phase 3
841
Monterrey, Oaxaca City
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Guadalajara, Juchitán de Zaragoza, León, Mexico City, Monterrey, Morelia, Oaxaca City, San Luis Potosí City
2020-12-07
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Durango, León, Monterrey, Naucalpan, Oaxaca City, Puebla City, Querétaro
2020-11-12
Active, closed
Hoffmann-La Roche
Phase 3
992
CD Mexico, Mexico City, Monterrey, Oaxaca City, San Luis Potosí City, Morelia, Veracruz
2020-10-09
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Durango, León, Mexico City, Monterrey, Naucalpan, Oaxaca City, Zapopan
2020-09-23
Active, closed
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung
DrugsAtirmociclib·Midazolam
Pfizer
Phase 2
362
Mexico City, Monterrey, Oaxaca City
2020-09-23
Active, closed
AstraZeneca
Phase 3
805
Aguascalientes, México, Monterrey, Oaxaca City, Querétaro, San Luis Potosí City, Veracruz
2020-05-05
Active, closed
Amgen
Phase 3
145
La Paz, San Luis Potosí City, Cuautitlán Izcalli, México, Oaxaca City, Toluca
2020-02-26
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
León, Zapopan, Cuauhtémoc, Tlalpan, Morelia, Monterrey, Oaxaca City, Querétaro City
2019-08-09
Active, closed
Exelixis
Phase 3
855
Aguascalientes, León, Zapopan, Monterrey, Oaxaca City, Mexico City, Querétaro
2019-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Guadalajara, Monterrey, Santiago de Quetaro, Madero, Chihuahua City, Mexico City, México, Oaxaca City
2018-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
La Paz, Guadalajara, Mexico City, Monterrey, San Pedro Garza García, Oaxaca City, Ciudad Madero, Mérida
2018-08-21
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Mexico City, Veracruz, Ver, Aguascalientes, Distrito Federal, Jalisco, Oaxaca City, San Luis de Potosi
2018-06-21
Active, closed
Eli Lilly and Company
Phase 2
234
Culiacán, San Bernardino, Mexico City, Oaxaca City
2016-09-14
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Chihuahua City, Cuernavaca, Culiacán, México, Oaxaca City, Zapopan
2014-11-26
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Oaxaca City
2013-09-09
Rows per page Showing 1–123 of 123
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/oaxaca-city

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 123 of those studies with a site in Oaxaca City.

How many clinical trials are recruiting in Oaxaca City?

50 of the 123 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 70 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Oaxaca City), 123 studies
PhaseStudiesRecruitingShare
Phase 3933875.6%
Phase 218514.6%
Phase 2/3866.5%
Not applicable100.8%
Observational100.8%
Phase 1/2110.8%
Phase 4100.8%

Most active sponsors

Lead sponsors with the most studies (Oaxaca City)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC3316
Bristol-Myers Squibb127
Pfizer104
Hoffmann-La Roche82
Eli Lilly and Company62
AstraZeneca41
Boehringer Ingelheim31
GlaxoSmithKline32
Janssen Research & Development, LLC30
Novartis Pharmaceuticals32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.